2 8&amp lt; = # )&gt

!" #

$ %

& %

'()

! 1

"

$ % 2

&

3'

) &*

:

!

"#

$%

& ! ' (

)# * + ) + , + - )''/ .

$ 0 1 + , 2 3 4

+ 5 6) " 7 ! ' 2

8& 9, :

"

+ 6

$#

, ;9 + ' < = # )>#

2

#,

" ? )

$ , ;9 '

@ # ' A ' B1 .

2 : :+ 6 8& 9, E , 40

+ FG ) 8 H I

J F : K' L

+1 2 , ) +1 ,100 5 L

5 L 1 ' + :( K' L '

$ , F +

+1 2 , ) '50 +1 ,100 5 L 1 5 L ) - ( P (

+1 .

"' " 2 ,

I (!

< , 8 2 '" I Q " R 8 ?! 4

8) "' ' + ?G ST ) - 6 (

' < = # +, ;9 . 2 )>#

- 6 8& 9, U ) ' 8& 9, " SA " ? ) ,#

V

$ , ;9 K'/ 8 A ' B1 ' @ #

K" ) W '

- L

.

+ K' L : +1 > "' K

(X- 8 ?! 5 1L $ , :2 , 8

+ &, Y + K' L " J

) 007 / 0 (P=

V E , :K'/&

+ &, W :+ !

< = # +, ;9 )

028 / 0 (P=

" ? ) ,# 2 )># '

) 008 / 0 K ! X,(P=

+1 $ , ' -

"' 2 , :100

)># +, ;9 U + &, < G 8 " ? ) ,# 2

!

) 034 / 0 (P=

V

+ &, K'/ 8

$ , ;9 B1 ' @ #

) 009 / 0 (P=

A ' ) 008 / 0 (P=

' -

$ , +1 > "'

&, < G 8 2 , +

:

$ , ;9

! A _P @ #

) 026 / 0 .(P=

< , " $ , : 1

+ , 2

"' ,100 1 + 5 L 5 L 1 , + ) : , ;9 + )>#

2 ,#

;9 ' " ? )

A

$ ,

@ # a

@ FG E , +

' ! !

, ;9 + )#

( ,# < = # ' " ? )

A1 ;9 +

$ ,

@ # 8 "' :

b

&, + ) .

1 : + , :2 :

,#

:" ? )

$ ,

@ # :

. 1391 19 ) 1 :(

12 - 21

&' () : 01 / 07 / - &. 1390

: 29 / 01 / 1391

c ' ) < P PF , 1

: ! - K 0X) :

$ U

$ :

V 'd , K )2

c K' L

$ :$ U :$ U + - I 5 1 K 0X) :+ - I K X) :

#

$ U : J! K L -

$ U + - I 5 1 K 0X) - I-

R J!

+ - I K X) - c K' L-

2?1 : 82944577 - J) 021 : 88622709 - + )' I 021 :

tmojarad@yahoo.com

X) 3 K' L g' ' B1 : :+ - I K X)

$ U?G + - I 5 1 K 0X) :

$ U?G

$ :

S, 2 JU, " + + h) "

9T

' :+ I' ) :+ I :+ I' ?) h) 0 <>/ T J

+A1 !

+, i F, + ' - -

8

I + 8 K # +) ) 8&, j $# * - :K ,# SJ

! T )

1 ' + ' :+A1 </ X, :K'/& (.

J " +- ) A

J K% !

h) W , !

> G :+ k ' +, = = ! :

" +

+, L > 2 8&, j 2 L h) '

<

8 i 19, ) +@ lm ! 8

$' "' Y a

+, E L

- :

+, + I

' +A1 </ X, * - -

# A

$ X) 8&, j X K

2 8 !

( 8 "

+, S JF + - U ' +) , ! J)

) 2 8 J :n oX $ ," + a :+ h) " .(

2 8 K X I " $ ,

( c J!

$ , " K ? 5' ' +@ lm 0X I < , ' !

K

+, noX, + T 8 J)

p $ , 8 2 8 8j .

W +T

+1 , 8P ' 2 : j S, - !

) j' q/J V

W $ p l

" !

( ! lm 7 r, Q Y k

( :i

" , ' :

T " + J!

) :2 3 V( :K'/&

' i 19, ) 1J ' + < p Bj , < , "

+, A ' B1 L

) :2 3 2 sJ! .(

t A

K L

+ ) ' X " +- )

S X

!

"#

$%

?1 o, < & 9, . +

K $ X)

8 )

$ T

+, K J!

2 T ' -

: u "

J 8

A) )

4 - 6

' X (.

S X " +- ) = $ I

!

$% "#

: P)

u 2 6 +JU,

h) " .

nT - 81Jj " :+@ J -

K I 2 + !

!

' " ? ) ,# < = # ( )# ' ;9 :i o,

" ? ) ,# 2 )>#

8 B # A) ' B1 h) +@ !

$ , , + ;9 ' 5 A

8 @ #

$ nT - " +

+, A &, !

-

) 6 - 7 :89 2 J! .(

8

$ I )' X 1

$ , ;9 : A ' B1 ' =

) @ #

2

+, !

.

$ ! : 0 7 Y "

K ?

d, , "

+! L K + )# G T

+ ) : J!

+, "

- ) 3 :v rT 2 .(

1 + , 2 8

$

JU, 2 , K , d L K , p J1 5 ) +

Silybum

marianum

, +

!' L " 8 - +

)''/ 5 ) 8 G "

$ 0

! X 1

S K - )

8 ) .(

H K $ X) < & 9, )

8 1 + , 2 G T

+ )#

K 8j S + )

! BA '

!

= $ I U, ' "#

!

'

&

I R

" , '

!

, + - K'/& . 3 4 <

U + KV ,' P, BA

1o 8 Tw 1L

$ 8 ' K -

# 5 0 ! B

X) I ( x ' I : A 2

=! _ !

, +

! ) :9 10 k .(

2 8& 9, : Xo +

$ , $#

J 1 A + :2, , :"'

=! ' i k A

!

' ' +

"

+

! ,

, :W + ' - +

K - K $ X) )

11 V( sJ!

2 T +

$ X) < & 9,

K

8 )

1 + , 2

! <

L ! +

' 1

3 4 :$ T '

$ Y

"

+

& ' S L + J + , + -

) 13,12 V( F) 8 8

+

! ,"#

! 0X +

noX, K - 8

1 + , 2 , 8

$

Uj S

+

, ! ' 1 ilj +

# zA 8 ' !

$ :

! BA

P,

' ' 1

, $ T LDL

+ Bj , ' -

0JXk 1

' , $ T HDL

+ L ) 14 8 8j .(

: a 8

! h) +

+, B1 ' A )

:2 3

"# '( ( )# $ -

A !

1Flavonolignans

) ,# 2 )># ' < = # h) +A1 '

" ? 8

$ T ST

+, )

1 +1 + Y " ' (

< 2 ,

+ )# ' + { ?a +, + )

- ) 10 V(

+ 2 l

:

+1 6

2 , ( )# +, ;9

' < = # !

,# 2 )>#

$ , $ , ' " ? )

' A ' @ #

B1 E ,

! G

+ + F

K - : _

L + , 2 '" I .

+ , -!

+ 6 8& 9, 2 :

"

? ) + FG E , 40

' %)

$ U : I )) +)"' K ' F, (

240 -

- K ? 5 L 300

$ a 5 J . , !

21 - 8j 23

+ ) K' L L

! 3

K R? ! + 4

) -

$ a . 8 i# 8 8) "# ! v ro, lm ' +X

E ,

| : I 5 } T -)

< , 8 ( 8 ?! 6

- +

S ' I + :2J4 . ' !

SJ&

8 G !

- U +1, ) _ K -

,#

) (NIH

? ' U0)

< ) a " K

8 X ST j , +1J ! ! ' +! 0X ,"#

5 6) E , 8 $# " + 2 .

) + FG !

a ' +& AY _ - 8 - K ? - )

< , 8)

14

" J U)# 5 1L $ , :( +1 , 130

5 L

+ )

15 2 (.

v rT : ' ' 8 A- "

'

@ , 8 8 0) T - K ?

K - lT $ T (6a .

"

' a ) $ a ! +1 , 1

E , . Y 8 !

8 + r

K' L 5 +@ 8

K' L : :

K' L F

J 1

+ , 2 : J0 )

$ J # ) ( , 100 1 + 5 L

5 L 1 :( K' L ' +

J F + K' L '

1 + , 2 ) ' 50 , 100 1 + 5 L 5 L 1

) - ( P ( .

"' 1 + , 2 ,"#

< X I

< 1

R) '

!

- i o ) j , )

16 1 (.

+ , 2 :

" RI "' 10 Q

'" I 2

< , 8 8 ?! 4

?G ST ) +

8) "' ' ( 6 - + .

E , $ J) ' " : !

2 '" I : J0 )

,#

ST ' "' W < G 8 (

$ , 8 + ?G

+1 , 60 5 L 5 L 1

8

< G 1F,

- K ? W c 2

(U) "' .

" RI

:Q JY

$

"

+ a $ :< ) 8) J)

| T

$ a " K - )

1L -) :i

$ U (

j' ' - K J L

_P '

a

< ) +

" > $ , +1 , 50

5 L

+ 8

" > $ T $ , +1 , 250

5 L

+ : h)

U{ W c 8) # 2 L

+, :

& 81a , 8

*' - J K

& !"' 8 A . :

: T I h) " (@/

E , +T ) $"' ! ' :" :+- ) I 8 !

H

- K E , 5 J $ I $"' ! q J4 .

!

- K

$"' $ , 2 & . 1L '

5 "' 5

" SA

5 6) ,"#

'

$ I 8 ?!

! '3

" RI6 ,"#

: 8

5 6) K" ) .

5 1L $ , L

:

E' _

1L +J )#

"

$ U :+J - " -) (

? K , ' = "

)' = ) W ,# :20 Y (

| , , ) )510

- 5 6) .

! "# $ # ! & ')

) * (

8 ( )# +, P, $ '#

' A !

" ? ) ,# 2 )># S, - +A1 )

(ALT

< = # '

" ? ) ,#

) (AST

"

8 8j ' + J - !

U)# SJ&

$ U :+J - ") Q A9 ' (

H ) $

L K ? ) + F , ' .

+ ,#- ./* 0 * $ 1 -'

E' 8 $ a 2 X ' $ I " RI

1

2 X )

G $ a

+ /T B1 :(

$ " A '

1Euthenesia

' 2 1F, X - " RI ' K - j WXT

$ J) : R= ' K - 2 " q &

) L j ! 8 8

< , 8 R K J!

' )c J! K 0 8P 2

1F, ' ) L K )c J! 8P ' 5000

K )c J!

- c ? ) :K - B o " L 1j .

( )#

2 x ' I ' !

! : , K - 8 ?L Sa , +, J 4

+ ) 8j L

so c ? ) ) - 5 6) (

" RI .

:K - j 1F, 8 P " 7 ?- + ' 1F, :c ? ) 5 6) i 2 " o 7 ?- 1F, " ' - 8 o ' K

+ ' :

- K ? 6

K" ) .

$ , ;9 L

@ #

' W ' MDA

SJ&

,# : J0 ) Q A9 ' (

$ ' H )

- 5 6) ) + F , .

2 3 40 *

' E' 8 2 x ' I 6

SJ&

,# : J0 ) - 5 6) (

) 17 .(

'& - '

H ) +, J : ,# h) "

8

< G 2 0) , 7 F)±

&, L $ noX, " RI .

W , I z " $ -

K

! 5 6) ) '' L J

7 ) J :( 8 P,

K' L " W ! , I ! H ) + " & ' SA !

:

"

$ ,"#

' R) ' )#

8 Y K' L 8 P, ' (! !

+) ," ! I " W ! :

$ ,"# "

8 9 R) '

'

' + +A P&

Uj SA H ) 8 P,

! , & '

K' L : + $ ,"# "

K ? +j'"

L

;9 K'/& .

+ &, : 05 / 0

P<

- 8 L h) ! )# +, J .

5 ) " ,# )# 5 6)

< J0 8o ))

5 / :3

2006 - K ? (

. .% /

+ &, <' ? K' L 2 $"' h) "

! : SA 5 "'

X) K ! X, ,"# "

J F K' L .

+1 8 ?! - " RI $"' +& AY W :2 ,

$ X) V

K' L " J $"' 2 k ! .

+ &, ! W :(X- 8 ?! $ I + K' L ,"# " SA 5 "' 8 P, )

014 / 0 (P=

K ! X,

L + K' L , &4' 2 J! . K

+1

$ , 8 2 , +1 , 50

j' ) 5 L 1 5 L

V - J F + K' L $"' ! : 0 7 Y "

+1 > "' 2 ,

) +1 , 100 5 L 1 5 L (

?! $ I + K' L 8 P, + &, a (X- 8

J )

029 / 0 ) (P=

J) 1 V( + &, <' ? :2 sJ!

K' L 2

" SA 5 "' 5 1L $ , v rT !

X) ,"#

8 ?! $ I .

$ , :(X- ' 5 !

K' L ' + K' L 5 1L

J F + !

+1 3 a 2 , ,

+ &

) 0005 / 0

P<

01 / 0

P<

" X (

K' L V

6 8 k ! +1 > "'

:2 ,

8 ?! 2 X ! 5 1L $ ,

$ X) ! .

+#!

1 8 ?! $"' < p -

~1 o, ! E ,

' + FG !

+1 K - J + ,

2

* . 05 / P<0 8 P, ) SA 8 ?!

K' L $ J!

(.

+1 > "' $ , F + K' L :K'/&

:2 ,

8 ?! $ I 5 1L $ ,

(X- ' 5 !

8 Y

+ &, K X) $ , + K' L " J

) 007 / 0 .(P=

+1 J F K' L :2J4

+ &, ! 2 ,

) $ X) K' L 8 P, , I 2 J))

2 .(

+#!

2 8 ?! 5 1L < p -

~1 o, ! E ,

+ FG !

+1 J F + '

2 ,

* . 01 / 0 P<

:

**

005 / 0 P<

:

0005***

/ P<0 8 P, ) SA 8 ?!

K' L $ J!

:( 05# / P<0

8 ?! $ J! + K' L 8 P, ) (.

89 # ' 2 :' * ./*

) (ALT

K" )

" ? ) ,# 2 )># ( )# +, ;9 L

K' L

+ F ~1 o, !

,"# " SA 5 "' '

$ I 8 ?!

(X- - noX, J))

3 8 ( ,# h) "

" SA 8 ?!

,"#

&, <' ? +

K' L 2

!

+J) - V ' + K' L ' ( )# 2 ;9 8 k !

J F

+1 2 , : 3 a 2 I r o,

"

K' L ,# 2 )># ( )# ;9 + .

" ? )

$ I 8 ?!

(X- noX,

m ' ( W 8 -

&, + K' L

J F ' !

> "'

+1 2 , j' K' L .

2 ;9 ) + !

( )#

$ I 8 ?!

(X-

q A ) W

' 8ha/, S

&, + ) 008 / 0 (P=

" SA 8 ?! 8 P, ,"#

$ X)

L .

J F + K'

+1

"' 2 ,

!

> ' 2 @ I

( )# 2 ;9 $ , )

$ I 8 ?!

(X- J + K' L 8 P, V

;9 8 Y 8

J F + K' L ( )#

+1 2 ,

$ , 8 100

+1 , 5 L 1 5 L + K' L " J

<' ? 2 8

&, ,# h) "

+ )

034 / 0 (.P=

+#!

3 ,# 2 )># ( )# ;9 - 5 " ? )

E ,

+ FG !

K - J + ' +1

2 ,

* . 05 / P<0 ' 01**

/ P<0 8 P, )

K' L $ J! SA 8 ?!

:(

# 05 / 0 P<

+ K' L 8 P, ) $ J!

(.8 ?!

89 # '< =*' *./*

) (AST

K" )

" ? ) ,# < = # ( )# +, ;9 L

K' L

~1 o, ! ,"# " SA 5 "'

'

$ I 8 ?!

(X-

" RI ,"#

- noX, J))

4 8 ?! 8 (

" SA ,"#

:

&, <' ? ,# h) "

+ 2 K' L

!

+J) ~1 o,

-

< = # ( )# ;9 + .

" ? ) ,#

$ I 8 ?!

(X-

W 8 - noX,

! (

&, m ' +

K' L

J F

"'

+1 >

2 , j' 2 ;9 ) + K' L .

( )#

$ I 8 ?!

(X-

q A ) W

' 8ha/, S

&, + ) 028 / 0 (P=

" SA 8 ?! 8 P, :

2 J!

$ X) K' L

+1 6 '

K' L 8 2 , +

"' " 5 s !

8 P, ( )# 2 ;9 ) ) !

+ &, 9 + K' L

! !

.

+#!

4 5 " ? ) ,# < = # ( )# ;9 - E ,

+ FG !

K - J + ' +1

2 , . 05* / P<0 8 P, ) SA 8 ?!

K' L $ J!

(.

A ./*

+ ,#- -' 1 )

(MDA

K" )

$ , ;9 L

#

@ K' L

~1 o, !

$ I 8 ?!

(X- K' L , I 2 8 - noX,

J F

+1 > "' 2 ,

:

! W

&, m ' r o, +

) +, $ X) K' L 8 A

! .

+ K' L

$ I 8 ?!

:(X-

$ , ;9

#

@

+ &, ' 8ha/, S W K' L 8 A )

$ X) )

008 / 0 (P=

' K' L

!

J F +

"'

+1 > ' 2 @ I !

2 , :

$ ,

$ ,

#

@ K' L 8 A )

J +

V K'/&

J F + K' L

+1 > "'

$ , 8 2 ,

+1 , 100 :5 L 1 5 L

$ , ;9

#

@ $ I

8 ?!

(X-

&, Y 8 +

+ K' L " J J))

5 ( ) 026 / 0 (.P=

+#!

5 $ , $ , -

A @ #

E ,

' + FG !

K - J + +1

2 , 05*

/ 0

P<

' 01**

/ 0

P<

8 P, ) K' L

:( 05#

/ 0

P<

+ K' L 8 P, ) (.

A B./*

+ ,#- -' 1 )

(MDA

K" )

$ , ;9 L

#

@ B1

J F K' L , I 2 8 - noX,

"'

+1 >

2 ,

&, m ' r o, ! W +

A )

+, $ X) K' L 8

! J)) 6 + K' L (.

$ I 8 ?!

:(X- , ;9

$

#

@

S W

+ &, ' 8ha/,

$ X) K' L 8 A )

) 009 / 0 (P=

' K' L

!

J F +

"'

!

+1 > ' 2 @ I 2 ,

)

$ , $ ,

#

@

K' L 8 A ) J +

V

;9 8 <' ? 2 k !

+ &, ) .

+#!

6 $ , $ ,-

B1 @ #

E ,

' + FG !

K - J + +1

2 , 05*

/ 0

P<

' 01**

/ 0

P<

8 P, )

K' L (.

0-

E , 8 $ X) + 2 H )

W + !

+ &, 2 )># ' < = # +, ;9

" ? ) ,#

) +1 $ , . U > "' 2 ,

&, < G 8 " ? ) ,# 2 )># +, ;9 +, !

!

$ , ;9 .

@ #

+1 $ , ' - A ' B1

< G 8 2 ,

$ , ;9 &,

! A _P @ #

.

! K' L $"' J +

F J

+1 2 , 2

+ +,

$

! < 8 1L =

J W

3 4 ' +

A ) $#

J! . 2 8& 9, :t A '

$ J!

) 2003 ' (

+1 1J 89 2 ,

$ X) + < a ) I

'/ 2 8 ')

$ 0

Uj

B # S, ) I h F,

$

T W J 1L = ! < Q Y 2 " ' K J) SJ +, J )

10

< " +Xo 4 a + q> J a (.

+1

E , $ T ! 2 ,

+, + !

$

A ) , 2 8

@ )'/ :K'/& V h) +@ !

+1 +, p , K L " Q X, 2 , )

S & Q Y "

( )# &

, A !

d

< ! ( , '

" !

81Jj

!

& ' A "/ ? ( )# &

$ T ! Uj " $c 1L ' " 1L '

3 a 8 $"' XL +& AY

J) SJ )

12 :8 A (.

8 8j

4 a + 8 :

' " K ? ,

Bj , 8 L 6 2 '" I W

6

* ) j +@ J - u 1

+,

;9 ' L

$# 2 )

8 1 $ P 1

2 ) 8F- , !

8

+, S a )

1 V( , < l +1

2 ,

;9

+, $ T 1L

$ q J " $# + ) I | T < 8

( )# & S & 81Jj

( , ! , A !

< !

= ' ! ' , 2 7 r, AU ' !

A ) +)/• ' + k ) < P PF H ) .

5 6

u " +Xo :K - J

!

h) W ,

8

X 1

+, - ) :6 18 .(

:89 2

8 :$ ," -lL ' "' A)

+, + +a ) $ ,

8

, +T ;9 2 > Bj , 2 +, !

- 2 U 8

$ , $ , : U)#

+, + @ #

- ) 6 8 8j .(

8 8

S X X 1

!

+, $% "#

1 + J - € j B # Bj , 2 : -

T 81Jj "

+, = ' + x ' I !

Bj , 2 8 -

( )# $ - "#

! 8 +, $ T ST

2 8 L

( )# +T ;9 89 h) B1 ' A 8 t , + !

$ T ST " ? ) ,# 2 )># ' " ? ) ,# < = # +, ) 19 V( :2 sJ!

K $ X) ~1 o, < & 9, )

8

$ T +1G S1 " +

+, - ) 5 ) 4 a + .(

2 ;9

( )#

E , 5 !

;9 ' + !

$ , + E L 2 8 - K ! X, @ #

!

+) oJ! +1A 5:19)

.(

+1 6 :+ 2

$ , 8 > "' 2 ,

+1 , 100 5 L 1 5 L

;9 ! Bj ,

" ? ) ,# 2 )># ( )# +, ;9 ! ' L A Xo .

+ , < "

+1 2 ,

+, 4 a Q PF

! < 8 $ +L !

$#

: 8

+ )# G T $ 1

' + )

P

7la ( +L

$% "# ! A )

) 8 - 10 v rT 2 .(

$ X)

+T 8 K - K

h) ! @ )'/

+1 2 , +, Bj , )

&

)#

+ )

& X ' $ !

)#

(

!

)#

+ ) + ) L ) 10 +, B 2 8 ( )

!

$ I

= 8

- 8 - A)

) 8 2 8 (

+, T

$ , ;9 ! )

' A @ #

) 4 a + " ? ) ,# 2 )># +, ;9 3 a J) 8 j

+1 , " 0 o .

2 ,

+, 4 a + A ) $# W J 1L = ! 8 $

8 2

! Q Y "

U) <> rF, ;9 $ +

$ / " 1L )

advanced glycosylation end-

products

8) X) ' ! Bj , (

$# !

$ , 81Jj "

+, + +a ) @ # L

) 12 .(

" $ T 1L 8 K - noX, 89 2 )' X Bj , < ,

1 = $ I

!

+, 7 !

$# <> rF, 8 +U , 2 8 L

$ , h) +, @ #

L ) 1 V(

< A Y T 2 J! 8

+, W J 1L = ! G T

< - " )

! $ ! )

3 .(

" . ' 1

8

$ , :8G/T Y

< , "

1 + , 2

"' , 100 1 + 5 L 5 L 1

, +

, ;9 )

+ )#

( )>#

2

,#

A ;9 2 sJ! ' " ? )

$ ,

@ #

, ;9 ' ! !

+ )#

( ,# < = #

" ? )

A1 ;9 ' +

$ ,

@ # 8 "'

b

&, +

) K" ) . L

& ;9 )#

(

! +

h)

">

I '

R

;9 6 ' " ,

+

)#

+ )

! AY

&

+ h) 1L

$

< 89

, 1 + , 2 a sJ! '

2 Xo +

"'

!

# < & 9, ' >

+ G 8 , + - .

! / !

&

Ja 4 a 8 P, ,

+ X!'%I )' &, +

K 0X)

' X B , 8 P, $ L ) ' K - 5 6) ! -

() T " T A

r)

! - + - I K X)

+, 5/ < X ,"# 5 6) 8 WJ )

.

2 :

1- Tripathi BK, Srivastava AK. Diabetes Mellitus: Complications and therapeutics. Med Sci Monit. 2006; 12(7):

RA130-47.

2- Suji G, Sivakami S. Approaches to the treatement of diabetes mellitus: an overview. Cell Mol Biol. 2003; 49(4): 635- 9.

3- Shapiro K, Gong WC. Natural products used for diabetes. J Am Pharm Assoc(Wash). 2002; 42(2): 217-26.

4- Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, et al. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud. 2010; 7(1): 15-25.

5- Descorbeth M, Anand-Srivastava MB. Role of oxidative stress in high-glucose- and diabetes-induced increased expression of Gq/11alpha proteins and associated signaling in vascular smooth muscle cells. Free Radic Biol Med.

2010; 49(9): 1395-405.

6- Chang YC, Chuang LM. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res. 2010; 2(3): 316-31.

7- Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev. 2010;

131(4): 276-86.

8- Hale Z, TunalJ T, ErkanlJ G, Yüksel M, Ercan F, Lener G. Silymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injury. Burns. 2007; 33(7): 908-16.

9- Láng I, Deák G, Nékám K, Müzes G, González-Cabello R, Gergely P, et al. Hepatoprotective and immunomodulatory effects of antioxidant therapy. Acta Med Hung. 1988; 45(3-4): 287-95.

10- Soto C, Recoba R, Barrón H, Alvarez H, Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol. 2003; 136(3): 205-12.

11- Flora k, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998; 93(2): 139-43.

12- Abascal K, Yarnell E. The many faces of Silybum marirnum. Alternat Complement Ther. 2003; 9(4): 170-5.

13- Sharma DK, Hall IH. Hypolipidemic, anti-inflammatory and antineoplastic activity and cytotoxicity of flavonolignans isolated from Hydnocarpus wightiana seeds. J Nat Prod. 1991; 54(5): 1298-302.

14- Sobolová L, Škottová N, VeReSa R, Urbánek K. Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats. Pharmacol Res. 2006; 53(2): 104-12.

15- Sedaghat R, Roghani M, Ahmadi M, Ahmadi F. Antihyperglycemic and antihyperlipidemic effect of Rumex patientia seed preparation in streptozotocin-diabetic rats. Pathophysiology. 2011; 18(2): 111-5.

16- Shaker ME, Shiha GE, Ibrahim TM. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis. Eur J Pharmacol. 2011; 670(2-3): 593- 600.

17- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-54.

18- Yanardag R, Bolkent S, Ozsoy-Sacan O, Karabulut-Bulan O. The effect of chard (Beta vulgaris L. var. cicla) extract on the kidney tissue, serum urea, and creatinine levels of diabetic rats. Phytother Res. 2002; 16(8): 758-61.

19- Salmela PI, Sotaniemi EA, Niemi M, Maentausta O. Liver function tests in diabetic patient. Diabetes care. 1984;

7(3): 248-54.

Abstract Original Article

The effect of chronic silymarin on serum level of some enzyme markers and tissue level of malondialdehyde in

diabetic rats

M. Roghani¹, T. Baluchnezhad-e-mojarrad², F. Roghani Dehkordi³

Background and Aim: Diabetes mellitus causes enhanced oxidative stress due to increased production of oxygen free radicals and decreased activity of antioxidant defense system. Flavonolignan Silymarin has an antidiabetic effect. This study was conducted to evaluate the effect of its chronic administration on serum levels of aspartate and alanine aminotranferase; and the heart and liver level of malondialdehyde.

Materials and Methods: In this experimental study, 40 male Wistar rats were divided into 5 equal groups, i.e. control, Silymarin -treated control (100 mg/kg), diabetic, and two Silymarin- treated diabetic groups (50 and 100 mg/kg). Silymarin was daily administered (i.p.) to each of the group members ten days after streptozotocin injection for 4 weeks. Serum levels of aspartate and alanine aminotranferase were measured both before and at the end of the study. In addition, level of malondialdehyde (MDA) was measured in the liver and the heart tissues on the basis of the reaction of thiobarbituric acid.

Results: Serum glucose level in high dose Silymarin-treated diabetic group was significantly lower as compared to diabetics in the sixth week (P=0.007).Moreover, diabetic rats showed a significant increase in their aspartate serum level (P=0.028) and alanine aminotranferase (P=0.008) and Silymarin treatment only significantly reduced serum level of alanine aminotranferase (P=0.034). In addition, diabetes was followed by increased level of MDA in the liver (P=0.008) and the heart (P=0.009) tissues and high-dose Silymarin treatment significantly reduced MDA level only in the liver tissues (P=0.026).

Conclusion: Long-term treatment with silymarin at a dose of 100 mg/kg can attenuate serum level of alanine aminotranferase and hepatic MDA level and does not have any significant effects on serum level of aspartate aminotranferase and cardiac tissue level of MDA in the administered doses.

Key Words: Silymarin, Diabetes mellitus, Aminotranferase, Malondialdehyde, Oxidative stress

Journal of Birjand University of Medical Sciences. 2012; 19 (1):12-21 Received: Friday, September 23, 2011 Accepted: Tuesday, April 17, 2012

1Dept. Physiology, School of Medicine, Shahed University, Tehran, Iran.

2Corresponding Author; Dept. Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

tmojarad@yahoo.com

3Dept. Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran